230 related articles for article (PubMed ID: 15001336)
21. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.
Halperin JL
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):163-74. PubMed ID: 15151465
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.
Cleland JG; Shelton R; Nikitin N; Ford S; Frison L; Grind M
Eur J Heart Fail; 2007; 9(6-7):730-9. PubMed ID: 17360232
[TBL] [Abstract][Full Text] [Related]
23. Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation. Pooled analysis from the SPORTIF III and V studies.
Diener HC;
Cerebrovasc Dis; 2006; 21(4):279-93. PubMed ID: 16449807
[TBL] [Abstract][Full Text] [Related]
24. [Preventing cerebrovascular accidents during atrial fibrillation].
Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulation for atrial fibrillation in the elderly.
Halperin JL
Am J Geriatr Cardiol; 2005; 14(2):81-6. PubMed ID: 15785149
[TBL] [Abstract][Full Text] [Related]
26. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
Scardi S; Giansante C
Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
[TBL] [Abstract][Full Text] [Related]
27. New possibilities in anticoagulant management of atrial fibrillation.
Waldo AL
Rev Cardiovasc Med; 2004; 5 Suppl 5():S30-8. PubMed ID: 15619613
[TBL] [Abstract][Full Text] [Related]
28. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Tandoğan I
Anadolu Kardiyol Derg; 2007 Jun; 7(2):216; author reply 218-9. PubMed ID: 17513230
[No Abstract] [Full Text] [Related]
29. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Kiraç FS
Anadolu Kardiyol Derg; 2007 Jun; 7(2):214-5; author reply 218-9. PubMed ID: 17513229
[No Abstract] [Full Text] [Related]
30. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
31. Aspirin bias in SPORTIF III trial.
Vadivelu MK
Lancet; 2004 Jun; 363(9426):2091; author reply 2091. PubMed ID: 15207972
[No Abstract] [Full Text] [Related]
32. Ximelagatran--promises and concerns.
Gurewich V
JAMA; 2005 Feb; 293(6):736-9. PubMed ID: 15701916
[No Abstract] [Full Text] [Related]
33. Preventing stroke in atrial fibrillation: the SPORTIF programme.
Lip GY
Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():25-30. PubMed ID: 15812201
[TBL] [Abstract][Full Text] [Related]
34. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.
Halperin JL
J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364
[TBL] [Abstract][Full Text] [Related]
35. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Agarwal S; Hachamovitch R; Menon V
Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
[TBL] [Abstract][Full Text] [Related]
36. Ximelagatran versus warfarin in the prevention of atrial fibrillation-related stroke: both sides of the story.
Testa L; Van Gaal W; Agostoni P; Abbate A; Trotta G; Biondi-Zoccai GG
Stroke; 2007 Jul; 38(7):e57. PubMed ID: 17510448
[No Abstract] [Full Text] [Related]
37. Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation.
McCullough PA; Dorrell KA; Sandberg KR; Yerkey MW
Rev Cardiovasc Med; 2004; 5(2):99-103. PubMed ID: 15184843
[TBL] [Abstract][Full Text] [Related]
38. Prevention of stroke in patients with atrial fibrillation.
Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
[No Abstract] [Full Text] [Related]
39. Stroke prevention in atrial fibrillation: anticoagulants and antithrombotics.
Ezekowitz MD
Am Heart Hosp J; 2004; 2(4 Suppl 1):31-5. PubMed ID: 15539973
[TBL] [Abstract][Full Text] [Related]
40. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
